An omega-3 index test measures EPA and DHA as a share of the fatty acids in your red blood cell membranes. What you pay is driven less by the marker than by how it is bought, whether it sits alone or inside a panel, whether a provider orders it, and which laboratory runs the analysis.
The marker is rarely sold by itself, because the same red cell sample is usually analysed alongside other cardiovascular markers. For the Advanced Cardio Add-On, the current price is shown with the panel details on this page, next to the full list of what the panel includes.
The omega-3 index is the combined amount of EPA and DHA expressed as a percentage of the total fatty acids in red blood cell membranes 1. That is a composition measurement, not a count of how much fat is circulating in your plasma at the moment the needle goes in.
In practical terms, the laboratory separates red cells from the rest of the sample, extracts the membrane fatty acids, and quantifies them by chromatography. EPA and DHA are then reported as a single percentage of all fatty acids present. Because this is a specialised fatty acid analysis rather than a routine chemistry run, it is not part of a standard lipid panel, and it is one reason the marker behaves differently from cholesterol on a price list. You can read more about the marker itself on the Omega-3 Index page.
Levels differ substantially between populations and regions, and a 2024 global review mapped that variation in detail across many countries 2. In other words, there is no single number that everyone with a normal diet lands on.
Red blood cells live for roughly four months, so the fatty acid composition of their membranes changes slowly and averages out your intake over that window. A large fish meal the night before the draw does not meaningfully move it, and neither does skipping fish for a few days.
Studies suggest that a sustained increase in dietary EPA and DHA raises the measured index gradually over weeks rather than hours 3. That slow response is the point of the marker. A food diary estimates what you intended to eat; the index estimates what your membranes actually absorbed and retained, which also accounts for differences in absorption and in the form consumed.
It also means repeat testing is only informative after enough time has passed for membranes to turn over. Retesting too soon mostly measures noise, and the right interval to recheck is a conversation to have with a clinician.
The result comes back as a single percentage, and most laboratories group that percentage into bands drawn from the research that first proposed the marker 1.
| Omega-3 index (% of total red cell fatty acids) | How it is usually described |
|---|---|
| Below about 4% | Lowest band in the original proposal 1 |
| About 4% to 8% | Intermediate band |
| Above about 8% | Highest band, described as the desirable target in the original proposal |
These are typical laboratory reporting bands rather than diagnostic cut-offs, and reference ranges in general vary by laboratory, method, age and sex. Always read your result against the range printed on your own report.
Observation, meaning, next step is a useful way to read it. The observation is a percentage. What it may reflect is your habitual EPA and DHA intake over the preceding months, filtered through how your body absorbs and stores those fats. A result in the lowest band is suboptimal rather than a diagnosis of anything, and it is worth discussing with a clinician alongside the rest of your lipid and cardiovascular picture rather than acted on alone.
A higher omega-3 index is associated with lower risk of death from coronary heart disease in the analysis that first proposed the marker 1, and later reviews have examined the same relationship across different populations 4. Broader reviews of EPA and DHA in cardiovascular health describe the evidence as supportive but not uniform across trial designs and endpoints 56. No single blood marker predicts an individual outcome, and this one is no exception.
Most people test it because intake is hard to estimate and the number is otherwise invisible. A few specific situations come up repeatedly.
People following plant-based eating patterns often want to know whether conversion from plant sources is producing meaningful EPA and DHA levels, and a scoping review of plant based omega-3 sources concluded that conversion efficiency is limited and variable between individuals 7. Measuring removes the guesswork.
Research suggests that EPA and DHA blood levels relate to measures of brain structure and function in observational work 8, and one study of older women examined the erythrocyte omega-3 index in the context of ambient fine particle exposure and brain aging 9. These are associations in populations, not predictions about any one reader.
The balance between omega-6 and omega-3 intake has also been studied as a factor in metabolic health, with one review arguing that a higher omega-6 to omega-3 ratio is associated with increased risk for obesity 10. Elsewhere, omega-3 fatty acids have been examined in dry eye, where reviews describe the trial evidence as mixed 11, and practice guidelines have been published on the use of omega-3 fatty acids in major depressive disorder 12. Whether any of that applies to you, and what to do about a low result, is a clinical judgement, not a self-service one.
The cost of any blood test is built from several separate pieces, and the marker itself is often the smallest of them. Understanding the pieces explains why quotes for the same test differ so widely.
| Cost driver | Why it moves the total |
|---|---|
| Bundled or standalone | A marker inside a panel usually costs less per marker than the same test ordered on its own, because one draw and one accession fee cover everything |
| Laboratory method | Fatty acid analysis needs chromatography and a lab set up to run it, which is a different cost base from routine chemistry |
| Collection method | A venous draw with a phlebotomist carries a draw fee; a dried blood spot kit carries kit and shipping costs instead |
| Who orders it | Provider-ordered testing, direct-to-consumer kits and membership-based testing are priced on different models |
| Where the sample is collected | Collection at a patient service centre, a clinic or at home each carry different service costs |
| Repeat testing | A single test and a tracked marker rechecked over time are priced differently by most providers |
| Payment route | Self-pay pricing, insurance-billed pricing and pre-tax account spending are not the same number |
Two tests with the same name can also differ in what you actually receive. A bare numeric result is not the same product as a result reported with reference bands, trend data and an interpretation written against the rest of your bloodwork. When comparing, compare the deliverable as well as the marker list.
Coverage varies by plan and by the reason the test is ordered, so the only reliable answer is to check directly with your plan before assuming anything. Tests ordered to investigate a specific clinical problem are handled differently from testing ordered for general optimisation, and that distinction, not the marker name, usually determines how a claim is treated.
The Advanced Cardio Add-On is marked HSA and FSA eligible in the catalog, so pre-tax funds can generally be used for it. If you are coordinating with a plan, ask about the specific test code your ordering provider intends to use rather than the marketing name of the panel.
The omega-3 index is offered as part of an add-on cardiovascular panel rather than as a single marker, so it is ordered the way any panel is, through the membership, with the sample collected in one draw. FitScript is a labs-first membership built around biomarker testing, with 150+ biomarkers tested per year, interpretation by Atlas, the AI health advisor, and treatment decisions made by a licensed provider after reviewing the member.
The add-on groups the omega-3 index with other cardiovascular markers that go beyond a standard lipid panel. The exact marker list and the current price are shown with the panel details on this page, so check there rather than relying on a general description. Results feed into your FitScript, the personalised output Atlas writes from your own biology, which is where a single percentage stops being trivia and starts sitting next to the rest of your lipid picture.
If a result is outside the typical range, that is a starting point for a conversation with a clinician, not a conclusion. Any decision about treatment is made by a licensed provider who evaluates whether it is appropriate for you.
Less preparation is needed than for most lipid testing, because the marker reflects months of membrane composition rather than your last meal. There is nothing you can eat or skip the day before that will meaningfully shift the number.
Fasting requirements, where they apply, are set by the laboratory and by the other markers collected in the same draw, so follow the instructions that come with your order rather than a general rule. Beyond that, be normally hydrated, keep your usual eating pattern in the weeks before the draw so the result reflects your real baseline, and tell the ordering provider about any supplements you take, without changing them specifically for the test. If you are tracking the marker over time, keeping collection conditions similar between draws makes the trend easier to read.
This page is educational and is not medical advice. Discuss your results and any treatment decisions with a clinician or licensed provider who knows your history.
For what the panel includes and the price currently listed, see the Advanced Cardio Add-On panel details shown with this article.
The price depends on how it is bought, since the marker is almost always analysed as part of a fatty acid or cardiovascular panel rather than sold alone. For the Advanced Cardio Add-On, the current price is shown with the panel details on this page, alongside the full marker list.
Because the quoted number bundles several different things. The laboratory method, whether a phlebotomist draws the sample or a kit is shipped to you, whether the marker sits inside a panel, who orders the test, and whether you are paying out of pocket or through a plan all move the total independently of the marker itself.
No. A standard lipid panel measures cholesterol fractions and triglycerides in plasma. The omega-3 index measures EPA and DHA as a percentage of the fatty acids in red blood cell membranes, which requires a different analytical method and is ordered separately or as part of an advanced cardiovascular panel.
The Advanced Cardio Add-On is marked HSA and FSA eligible in the catalog, so pre-tax funds can generally be used. If you are unsure how your specific account treats a given purchase, check the account's own rules before paying.
Coverage varies by plan and by the reason the test is ordered, so check directly with your plan. Testing ordered to investigate a specific clinical problem is often handled differently from testing ordered for general health optimisation, and that distinction usually matters more than the name of the panel.
Fasting requirements are set by the laboratory and by the other markers collected in the same draw, so follow the instructions that come with your order. The omega-3 index itself reflects months of membrane composition, so a recent meal does not meaningfully change that particular number.
No. Red blood cells live for roughly four months, so their membrane fatty acid composition changes gradually with sustained intake rather than in response to a single day. That slow turnover is exactly why the marker is useful as a measure of habitual intake.
That is a decision for the clinician who ordered it. Because membrane turnover is slow, retesting before enough time has passed mostly captures measurement noise rather than real change, so the interval should be set deliberately rather than by habit.
Both collection methods are used for fatty acid analysis, and each laboratory validates its own method and reports against its own reference bands. What matters most for tracking is keeping the collection method and laboratory consistent between tests, since results from different methods are not always directly comparable.
Treat it as one data point, not a diagnosis. A result in the lowest reporting band is suboptimal rather than a sign of disease, and it is worth discussing with a clinician alongside your lipid panel, your history and the rest of your results before any change is made.